FLT3 and acute myeloid leukemia: Peripheral blood of an AML patient in complete remission has been found harboring specific T cells targeting an FLT3-ITD derived neoepitope, which secrets significant amounts of IFN-γ and Granzyme B after receiving the stimulation of this neoepitope [68].